How aware of advanced care directives are heart failure patients, and are they using them?

Canadian Journal of Cardiology

Volumn 27, Issue 3, 2011, Pages 376-381

  Habal, Marlena V ^a   Micevski, Vaska ^a   Greenwood, Sarah ^a   Delgado, Diego H ^a   Ross, Heather J ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; CARDIAC PATIENT; CLINICAL ARTICLE; COMPREHENSION; DEFIBRILLATOR; DISEASE EXACERBATION; DOCTOR PATIENT RELATION; FEMALE; HEALTH CARE UTILIZATION; HEART FAILURE; HUMAN; LIVING WILL; MALE; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RESUSCITATION; SEMI STRUCTURED INTERVIEW;

EID: 79960846785     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2010.12.067     Document Type: Article

References (27)

1. Naylor CD, Slaughter PM. Cardiovascular Health and Services in Ontario: An ICES Atlas. Toronto: Institute for Clinical Evaluative Sciences (ICES) and Heart and Stroke Foundation of Ontario, 1999.
2. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993;88:107-15.
3. Schocken DD, Benjamin EJ, Fonarow GC, et al. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2008;117:2544-65.
4. Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 2006;22:23-45.
5. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352: 225-37.
6. Goldman S, Johnson G, Cohn JN, et al. Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. Circulation 1993;87(suppl VI);VI24-31.
7. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult-summary article: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation 2005;1825-52.
8. Krumholz HM, Phillips RS, Hamel MB, et al. Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT Project. Circulation 1998;98:648-55.
9. The SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients: the study to understand the prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA 1995;274:1591-8.
10. Ong LM, de Haes JC, Hoos AM, Lammes FB. Doctor-patient communication: a review of the literature. Soc Sci Med 1995;40:903-18.
11. Knauft E, Nielsen EL, Engelbert RA, Patrick DL, Curtis JR. Barriers and facilitators to end-of-life care communication for patients with COPD. Chest 2005;127:2188-96.
12. Larson DG, Tobin DR. End-of-life conversations: evolving practice and theme. JAMA 2000;284:1573-8.
13. Tierney WM, Dexter PR, Gramelspacher GP, et al. The effect of discussions about advance directives on patients' satisfaction with primary care. J Gen Intern Med 2001;16:32-40.
14. Health Care Consent Act of 1996. S.O. 1996, Chapter 2. Last amendment: 2010, c.1, Sched.9. Available at: http://www.e-laws.gov.on.ca/html/statutes/english/elaws_statutes_96h02_e.htm#BK24. Accessed October 4, 2011.
15. Federal Patient Self Determination Act. SEC. 4751. Requirements for advanced care directives under state plans for medical assistance. 1990. Available at: http://euthanasia.procon.org/sourcefiles/patient_selfdetermination_act.pdf. Accessed October 4, 2011.
16. Stevenson LW. Rites and responsibility for resuscitation in heart failure: tread gently on the thin places. Circulation 1998;98:619-22.
17. Shrank WH, Kutner JS, Richardson T, et al. Focus group findings about the influence of culture on communication preferences in end-of-life care. J Gen Intern Med 2005;20:703-9.
18. Coppola KM, Ditto PH, Danks JH, Smucker WD. Accuracy of primary care and hospital-based physicians' predictions of elderly outpatients' treatment preferences with and without advance directives. Arch Intern Med 2001;161:431-40.
19. Desharnais S, Carter RE, Hennessy W, Kurent JE, Carter C. Lack of concordance between physician and patient: reports on end-of-life care discussions. J Palliat Med 2007;10:728-40.
20. Deep KS, Griffith CH, Wilson JF. Discussing preferences for cardiopulmonary resuscitation: what do resident physicians and their hospitalized patients think was decided? Patient Educ Couns 2008;72:20-5.
21. Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM. Management of implantable cardioverter defibrillators in end-of-life. Ann Intern Med 2004;141:835-8.
22. Sherazi S, Daubert JP, Block RC, et al. Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverterdefibrillator. Mayo Clin Proc 2008;83:1139-41.
23. Ahmad M, Bloomstein L, Roelke M, Berstein AD, Parsonnet V. Patients' attitudes toward implanted defibrillator shocks. PACE 2000;23:934-8.
24. Dunbar SB. Psychosocial issues of patients with implantable cardioverter defibrillators. Am J Crit Care 2005;14:294-303.
25. Eckert M, Jones T. How does an implantable cardioverter defibrillator (ICD) affect the lives of patients and their families? Int J Nurs Pract 2002;8:152-7. 2009.
26. Sears SF, Conti JB. Quality of life and psychological functioning of ICD patients. Heart 2002;87:488-93.
27. Harrington MD, Luebke DL, Lewis WR, Aulisio MP, Johnson NJ. Implantable cardioverter defibrillator (ICD) at end of life #112. J Palliat Med 2005;8(5):1056-7.